US stocks slump to lows late in session after reports of fresh semiconductor curbs on China

More motivated buyers than motivated sellers.

Travelers at Sacramento International Airport (SMF)

GE Aerospace falls after leaving earnings guidance unchanged

Jet engine maker GE Aerospace slid in early trading Tuesday, as its better-than-expected Q1 results were overshadowed by uninspiring guidance.

It reported:

Q1 adjusted revenue of $11.61 billion vs. the $10.71 billion consensus expectation.
Adjusted earnings per share of $1.86 vs. the $1.60 consensus estimate.

But management left full-year 2026 adjusted EPS guidance where it was at between $7.10 and $7.40, compared to a consensus expectation of $7.49 from analysts.

“We’re holding our full-year guidance across the board, given the macro uncertainty, though, with our strong start to the year, we are trending toward the high end of that range,” CEO Larry Culp said on the conference call.

GE Aerospace hit an air pocket in March as the start of the US war against Iran sent energy prices soaring and hurt expectations for the profitability of commercial carriers. A rally in April had pushed the stock close to positive territory for the year, but it’s solidly in the red after the results today.

Max Knoblauch1h

Trump says he doesn’t like potential United-American merger but would “love somebody to buy Spirit”

President Trump on Tuesday told CNBC that he doesn’t like the idea of a United Airlines-American Airlines merger, but would “love somebody to buy Spirit.”

“Maybe the federal government should help that one,” Trump said on Tuesday, referring to Spirit’s attempts to emerge from bankruptcy.

Trump’s thoughts on United-American are an update from last week, when White House Press Secretary Karoline Leavitt said the potential megamerger was “not something the president or the White House have an opinion on or are weighing in on.”

American and United shares dipped following Trump’s comments, as did Spirit rival Frontier Airlines.

Trump: "I'd love somebody to buy Spirit Airlines. Maybe the federal government should help that one out. I told my people." pic.twitter.com/YS1GAMPeQ3
— Aaron Rupar (@atrupar) April 21, 2026

Claire Yubin Oh & David Crowther5h

BYND rises on elevated volumes, has now doubled in the last 10 days after product revamps

Beyond Meat soared as much as 18% in overnight trading, extending a winning streak that has seen the stock nearly double since April 10, after gaining over 41% in yesterday’s session alone.

That’s a significant turnaround for the meat alternative company, which just three weeks ago was tanking after issuing weak sales guidance... with the company’s management laying blame on American society for its business struggles.

Beyond repair?

BYND has had two distinct moments in the sun: one as a bona fide startup stud promising to transform the food industry forever in 2020 and 2021, and the other as a meme stock, when the company suddenly found itself at the center of a retail trading frenzy last October after a tumultuous few years.

Sparking this latest tick higher appears to be a new product release from last Thursday, when the company revealed that Beyond Immerse, the company’s first functional beverage line, had signed a distribution agreement with Big Geyser — one of the country’s largest nonalcoholic distributors. That followed an update to its breakfast sausage range just three days earlier.

It’s a big ask for a new sausage or protein-packed drinks with fruity flavors — both highly competitive categories — to fully save a company that’s seen sales sink, losses balloon, and its share price crater through the years. But the product news, combined with Beyond appeasing Nasdaq regulators by finally filing its delayed 2025 annual report, seems to have been enough to reinvigorate investor interest, shaking off some concerns about a delisting.

Perhaps most importantly, however, is that retail traders are once again fishing in the higher-risk, higher-reward end of the stock market pond. Risk-on assets have ripped higher in the last few weeks as geopolitical risks calmed, bringing indexes to an all-time high and seeing meme-like stocks soar on speculative excitement rather than business fundamentals. Just from last week, we’ve seen Allbirds and Myseum skyrocket on surprise AI pivot news. Retail favorites like quantum name IonQ have also caught a bid.

But, where Beyond’s concerned, this ain’t 2021 yet. And it’s still nowhere near last October, either:

Per Bloomberg data, there’s still plenty of interest in betting against the company — short interest as a percent of the equity float is at 35% — but it still pales compared to the 83% level from its October high.

In simple volume terms, BYND traded only some $224 million as of yesterday — a tiny fraction of October’s busiest day, when $11 billion changed hands.

J. Edward Moreno5h

UnitedHealth beats Q1 estimates, raises annual outlook

UnitedHealth rose in premarket trading after it reported earnings results that beat Wall Street expectations and raised its full-year guidance.

For the full year 2026, the company now expects:

Annual adjusted earnings per share to be at least $18.25, up from the previous floor it set at $17.75 and higher than the $17.86 analysts polled by FactSet were expecting.

For the first quarter of 2026, the company reported:

Adjusted earnings per share of $7.23, higher than the $6.58 the Street was penciling in.
A medical cost ratio of 83.9%, lower than the 85.5% that was expected. The company said the decrease in spending on medical care was “driven by strong medical cost management and favorable reserve development, partially offset by consistently elevated utilization and unit cost trends.”

The company, which is the first of its peers to report earnings this quarter, was up more than 6% in early action on Tuesday. The stock is down 3.8% from the start of the year through yesterday’s close.

UnitedHealth’s rosy report also lifted some of its peers. Humana, CVS, Elevance Health, Centene, and Molina Healthcare were all up in premarket trading.

The sector has been under pressure in the past year as the cost of providing care, particularly for those on Medicare, has gone up. In the first quarter, UnitedHealth was able to grow its Medicare revenues by 1%, despite having about 1,000 fewer members, by raising the price of its premiums.

“Investors are likely showing signs of relief with this mornings pre-market on UNH,” said David Wagner, head of equity and portfolio manager at Aptus Capital Advisors. “The stock has had a volatile run over its last few earnings reports, largely dictated by surging medical costs in its Medicare Advantage business and regulatory shifts.”

Wagner continued, “While the stock has struggled for much of the past year, it is currently showing signs of a turnaround, or at least stability that investors are appreciating. The highlight of the report for me was the margins.”